GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Price-to-Funds-From-Operations

Alzinova AB (OSTO:ALZ) Price-to-Funds-From-Operations : (As of Apr. 27, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Alzinova AB Business Description

Industry
Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.